RESEARCH & DEVELOPMENT
Accelerating your innovation with scalable, high-purity DNA solutions
dbDNA™ technology eliminates traditional plasmid transition barriers, supporting you in delivering seamless scaling from R&D to GMP production.
OVERVIEW
With rapid turnaround times and flexible production options, dbDNA™ empowers researchers like you to advance your genetic discoveries effortlessly.
Advantages of using Touchlight’s technology in your workflows
dbDNA™ ensures smooth progression from early research to clinical application by removing manufacturing hurdles and optimising construct design.
Faster Production Timelines
dbDNA™ is manufactured using a cell-free enzymatic process, which dramatically reduces production time compared to traditional plasmid DNA.
High Purity and Safety
Unlike plasmid DNA, dbDNA™ contains no bacterial sequences or antibiotic resistance genes, eliminating the risk of unwanted immune responses.
Scalability and Complex Sequence Compatibility
dbDNA™ can handle large and complex genetic payloads, even those that are unstable or toxic in E. coli systems.
We can support your project
Comprehensive support available for your research and development applications
From candidate screening to GMP readiness, our services facilitate the seamless progression of genetic innovation.
Custom DNA production for early-stage research
Rapid feasibility assessments with R&D-grade dbDNA™
Scalable production tailored for preclinical studies
GMP transition support to streamline clinical development
Regulatory guidance for efficient market approval
Construct design optimisation for manufacturability
APPLICATIONS
Explore our applications for R&D with dbDNA™
Our scalable DNA technology accelerates applications across genetic medicine, from discovery to commercialisation.
RESOURCES
How dbDNA™ enhances your R&D scalability
Explore insights on how enzymatic DNA technology is transforming research workflows like yours, as well as supporting seamless clinical transitions.
